Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Enrolling by Invitation

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/Relapsed Central Nervous System Lymphoma

NCT06827782

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Enrolling by Invitation

Chidamide in Patients With Recurrent and Refractory Diffuse Large b

NCT05690191

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Second Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Enrolling by Invitation

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

NCT04491721

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Cancer Institute/Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College Beijing, China

View Trial Details

Not Yet Recruiting

A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

NCT07735533

Conditions: Diffuse Large B Cell Lymphoma (DLBCL), Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)

NCT07729397

Conditions: Anaplastic Large Cell Lymphoma, ALK-Positive, Anaplastic Large Cell Lymphoma, ALK-negative, Diffuse Large B-Cell Lymphoma (DLBCL), +17 more
Locations: Houston Methodist Hospital Houston, Texas, United States

View Trial Details

Not Yet Recruiting

Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma

NCT07725406

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

View Trial Details

Not Yet Recruiting

Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients

NCT07714421

Conditions: Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States

View Trial Details

Not Yet Recruiting

A Phase II Study to Evaluate the Efficacy of UF-KURE19 Cells in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

NCT07713459

Conditions: CAR T Cell Therapy, Diffuse Large B Cell Lymphoma (DLBCL), Follicular B-cell Non-Hodgkin's Lymphoma, +14 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Birelentinib Plus R-CHOP in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (TAI-SHAN19)

NCT07712588

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

Harbin Medical University Cancer Hospital Harbin, Heilongjiang, China

Hunan Cancer Hospital Changsha, Hunan, China

Cancer Hospital of Shandong Frist Medical University Jinan, Shangdong, China

View Trial Details

Not Yet Recruiting

A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

NCT07702851

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Lymphoma, Large B-Cell, Diffuse

Lymphoma, Large B-Cell, Diffuse trial results

Related conditions